Investors Capital Advisory Services - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 206 filers reported holding PDL BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
Investors Capital Advisory Services ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2015$94,000
+4.4%
18,706
+32.2%
0.02%
+11.8%
Q2 2015$90,000
-7.2%
14,146
+2.2%
0.02%
-5.6%
Q1 2015$97,000
-12.6%
13,846
-4.6%
0.02%
-14.3%
Q4 2014$111,000
+11.0%
14,509
+7.4%
0.02%
+5.0%
Q3 2014$100,000
-11.5%
13,509
+15.6%
0.02%
+11.1%
Q2 2014$113,000
+18.9%
11,691
+1.7%
0.02%
-10.0%
Q1 2014$95,000
-3.1%
11,491
-1.7%
0.02%
-13.0%
Q4 2013$98,000
+10.1%
11,691
+4.6%
0.02%0.0%
Q3 2013$89,000
+3.5%
11,1810.0%0.02%
-11.5%
Q2 2013$86,00011,1810.03%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2015
NameSharesValueWeighting ↓
HAYS ADVISORY LLC 1,037,600$6,672,0000.97%
Global X Management CO LLC 2,435,411$15,660,0000.86%
Advisors Asset Management, Inc. 5,373,113$34,549,0000.47%
Gotham Asset Management, LLC 7,233,838$46,514,0000.39%
TFS CAPITAL LLC 582,438$3,745,0000.37%
LOMBARDIA CAPITAL PARTNERS LLC 1,637,611$10,530,0000.36%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 95,122$611,634,0000.33%
FIRST TRUST ADVISORS LP 17,536,793$112,762,0000.29%
Arrow Investment Advisors, LLC 214,595$1,380,0000.28%
GSA CAPITAL PARTNERS LLP 954,853$6,140,0000.24%
View complete list of PDL BIOPHARMA INC shareholders